Personalized Genomic Medicine Research Center (유전체맞춤의료전문연구단)
Results 1-20 of 199 (Search time: 0.005 seconds).
No. | Year | Title | Type |
---|---|---|---|
199 | 2023 | 2023Article TNF-α secreted from macrophages increases the expression of prometastatic integrin αV in gastric cancerInternational Journal of Molecular Sciences, vol. 24, no. 1, pp. 376-376Mi Aie Hwang; Misun Won; Joo-Young Im; Mi-Jung Kang; D H Kweon; Bo Kyung Kim |
Article |
198 | 2023 | 2023Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
197 | 2022 | 2022Patent 세포 내 존재 단백질과 세포 외부로 분비되는 단백질을 동시 발현하는 이중 발현벡터를 포함하는 암의 예방 또는 치료용 조성물KR10-2021-0039575 (2021.03.26) / 10-2393402 (2022.04.27)원미선; 임주영 |
Patent |
196 | 2022 | 2022Patent SYT11 억제제를 유효성분으로 포함하는 위암 치료용 조성물KR10-2019-0129281 (2019.10.17) / 10-2377702-0000 (2022.03.18)염영일; 원미선; 반현승; 김보경; 박경찬 |
Patent |
195 | 2022 | 2022Article Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesisJournal of Experimental & Clinical Cancer Research, vol. 41, pp. 212-212Bo Kyung Kim; Da Mi Kim; Hyunkyung Park; Seon-Kyu Kim; Mi Aie Hwang; Jungwoon Lee; Mi-Jung Kang; Jae Eun Byun; Joo-Young Im; Minho Kang, et al. |
Article |
194 | 2022 | 2022Article DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapyExperimental and Molecular Medicine, vol. 54, no. 8, pp. 1236-1249Haejeong Heo; Jong-Hwan Kim; Hyun Jung Lim; Jeong Hwan Kim; M Kim; J Koh; Joo-Young Im; Bo Kyung Kim; Mi Sun Won; Ji Hwan Park, et al. |
Article |
193 | 2022 | 2022Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2022.01.01 ~ 2022.12.31 |
Research Project |
192 | 2022 | 2022Research Project MDH 저해제를 활용한 LKB1/KRAS-매개하는 암대사 조절 기전 연구 = Study on the LKB1/KRAS-mediated regulation of cancer metabolism using MDH inhibitor연구책임자 : 원미선 / 사업기간 : 2022.03.01 ~ 2023.02.28 |
Research Project |
191 | 2022 | 2022Research Project 암대사를 조절하는 MDH1/2 이중 저해 항암물질 개발 = Development of anti-cancer drug MDH1/2 dual inhibitor controling cancer metabolism연구책임자 : 원미선 / 사업기간 : 2022.01.01 ~ 2023.06.30 |
Research Project |
190 | 2021 | Patent | |
189 | 2021 | 2021Patent cyb5R3 유전자 또는 단백질을 유효성분으로 포함하는 암 예방 및 치료용 약학적 조성물CN201480064255.2 (2016.05.25) / ZL201480064255.2 (2021.02.26)김동욱; 원미선; 이영주; 반현승; 김보경 |
Patent |
188 | 2021 | 2021Article VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-β/ERK/RSK2 signalingBiochimica et Biophysica Acta-Molecular Cell Research, vol. 1868, pp. 118892-118892Joo-Young Im; Da Mi Kim; Hyunkyung Park; Mi-Jung Kang; Da Yoon Kijm; K Y Chang; Bo Kyung Kim; Mi Sun Won |
Article |
187 | 2021 | 2021Article DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathwayExperimental and Molecular Medicine, vol. 53, no. 4, pp. 643-653Joo-Young Im; Bo Kyung Kim; S H Yoon; B C Cho; Y M Baek; Mi-Jung Kang; N Kim; Y D Gong; Mi Sun Won |
Article |
186 | 2021 | 2021Article LW1497, an inhibitor of malate dehydrogenase, suppresses TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells by downregulating slugAntioxidants, vol. 10, no. 11, pp. 1674-1674H J Kim; M K Park; H J Byun; M Kim; B Kim; L Yu; T M Nguyen; T H Nguyen; P A Do; E J Kim, et al. |
Article |
185 | 2021 | 2021Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2021.01.01 ~ 2021.12.31 |
Research Project |
184 | 2021 | 2021Research Project [BRIDGE+] 2020년도 대학협력기관 간 융복합 프로그램연구책임자 : 이홍원 / 사업기간 : 2021.09.01 ~ 2022.01.15 |
Research Project |
183 | 2021 | 2021Research Project 다중유전체 분석을 통한 비흡연폐암의 신규치료타겟 발굴 및 기전규명연구책임자 : 박경찬 / 사업기간 : 2021.01.01 ~ 2022.03.31 |
Research Project |
182 | 2021 | 2021Research Project MDH 저해제를 활용한 LKB1/KRAS-매개하는 암대사 조절 기전 연구 = Study on the LKB1/KRAS-mediated regulation of cancer metabolism using MDH inhibitor연구책임자 : 원미선 / 사업기간 : 2021.03.01 ~ 2022.02.28 |
Research Project |
181 | 2021 | 2021Research Project 암대사를 조절하는 MDH1/2 이중 저해 항암물질 개발 = Development of anti-cancer drug MDH1/2 dual inhibitor controling cancer metabolism연구책임자 : 원미선 / 사업기간 : 2021.01.01 ~ 2021.12.31 |
Research Project |
180 | 2020 | 2020Patent 장형 위암의 예후 진단 마커KR10-2018-0125768 (2018.10.22) / 10-2136747-0000 (2020.07.16)원미선; 김보경; 김선규; 박경찬 |
Patent |